Archive by Author

Two Denver law firms win patent work from NIH: In the News

The Denver Business Journal profiles Swanson & Bratschun, LLC, who teamed with another firm to win a prestigious contract to handle biotechnology patents for the National Institutes of Health for 10 years. View the complete article as a PDF.

Comments Off on Two Denver law firms win patent work from NIH: In the News Continue Reading →

The Q Factor: In the News

Patent Ratings annual take on who prosecutes the highest-quality patents. Swanson & Bratschun, LLC received top honors in the Biotech category. View the complete article as a PDF.

Comments Off on The Q Factor: In the News Continue Reading →

Is Your Newly FDA-Approved Drug Eligible for Patent Term Extension?

We have recently spent some time determining whether a patent covering a drug which was newly approved New Drug Application (NDA) by the FDA, was eligible for patent term extension (“PTE”). The drug in question was the free base of the previously FDA approved salt. Under 35 U.S.C. 156, the term of a patent that claims “a […]

Leave a comment Continue Reading →